Enveric Biosciences Inc vs Enovix Corporation — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Enovix Corporation trades at $4.89 (market cap $1.11B). The key difference: Enovix Corporation is far larger — about 208.6× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ENVB | ENVX | |
|---|---|---|
Market Cap | $5.32M | $1.11B |
Sector | Health | Technology |
52-Week High | $17.40 | $15.93 |
52-Week Low | $1.28 | $4.84 |
Enterprise Value | $408.82K | $1.13B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ENVX trades at $4.855, down 4.05% today amid bearish technical signals. The company shows strong revenue growth potential with recent earnings beats but operates at a significant loss, reflected in a -499.64% net margin. Positive sentiment is driven by analyst consensus with a $12.75 price target and recent operational hires from Apple, though cash flow remains negative as production scales.
Outlook hinges on successful manufacturing ramp-up and smartphone battery qualification. High execution risk and cash burn present challenges, but leadership in silicon-anode technology offers long-term upside if commercial targets are met. Investors face volatility but potential reward from current discounted levels.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →